| Literature DB >> 32758340 |
Yunbo Fu1, Yuanxiao Yang2, Jianhong Shi1, Kausik Bishayee1, Luning Lin1, Yiyou Lin1, Yehui Zhang1, Liting Ji3, Changyu Li4.
Abstract
It has been shown that Acori tatarinowii rhizoma (ATR) extract can improve cognitive functions in Alzheimer Diseas (AD) patients or animal models. In this study, we have examined the activity of ATR in 3×Tg-AD model mice with different comprehensive behavioral tests like the Morris water maze and Y-maze test assay for behavior. Moreover, we performed LFB staining for myelin determination in the AD model mouse. By analyzing different pathways, we determined key proteins that are beneficial for ameliorating AD syndrome in the mouse. Periluminally, ATR treatment improved the learning and memory ability that was determined by comprehensive behavioral tests. Moreover, treatment reduces the p-Tau accumulation in the 3×Tg-AD mouse and the level of p-Tau accumulation was at per with the wildtype control mouse and improves the myelin lining in 3×Tg-AD mouse. In conclusion, our results indicate that ATR-treatment can improve the learning ability of AD model mice and the hyperphosphorylation of Tau protein was decreased. ATR can protect myelin lining from damage in AD syndrome.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32758340 DOI: 10.1691/ph.2020.0492
Source DB: PubMed Journal: Pharmazie ISSN: 0031-7144 Impact factor: 1.267